+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • April 2025
  • 293 Pages
  • Global
From
Future of Pharma - Looking Ahead to 2023 - Product Thumbnail Image

Future of Pharma - Looking Ahead to 2023

  • Report
  • April 2023
  • 58 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 181 Pages
  • Global
From
From
From
Hypoglycemia - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hypoglycemia - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 124 Pages
  • Global
From
From
From
From
Non-alcoholic Steatohepatitis (NASH) Market 2024-2028 - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) Market 2024-2028

  • Report
  • August 2024
  • 154 Pages
  • Global
From
From
From
Loading Indicator